Andersen Partners assisted DanCann Pharma in this transaction. DanCann Pharma was provided approximately DKK 30 million (before issue costs) in the oversubscribed IPO of units which…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
